Latest Healthcare Research Reports

Tag: biological safety testing products and services market research

  • Biological Safety Testing Products And Services Market Size Forecast To Achieve $11.34 Billion By 2030 With 13.1% CAGR

    Biological Safety Testing Products And Services Market Size Forecast To Achieve $11.34 Billion By 2030 With 13.1% CAGR

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Value Of The Biological Safety Testing Products And Services Market Projected To Expand During 2026–2030?

    The biological safety testing products and services market size has experienced substantial growth in recent years. This market is projected to expand from $6.12 billion in 2025 to $6.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.3%. Historically, this expansion has been driven by factors such as the increasing production of vaccines and biologics, the expansion of pharmaceutical manufacturing capabilities, heightened regulatory scrutiny concerning product safety, the broader adoption of cell and gene therapies, and the rise in clinical research activities.

    The market for biological safety testing products and services is projected to experience swift expansion over the coming years. This market is anticipated to reach $11.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This expansion during the outlook period stems from factors such as a heightened demand for sophisticated biologics safety assays, increased capital injection into automated testing platforms, the widening scope of gene and cell therapy pipelines, an escalating requirement for quicker release testing, and a stronger focus on reducing contamination risks. Key developments predicted for the same period involve a greater embrace of swift microbial detection techniques, a surge in the need for automated sterility testing systems, a broader application of PCR-based safety testing, the enlargement of outsourced biological testing services, and a reinforced commitment to testing solutions that adhere to regulatory standards.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

    Which Drivers Are Advancing The Biological Safety Testing Products And Services Market Growth?

    The expanding requirement for gene therapies is anticipated to drive the future growth of the biological safety testing products and services market. Gene therapy is defined as a medical strategy that employs genes to cure or prevent diseases by substituting, altering, or supplementing deficient genes. Enhanced investment and research into gene mutation, alongside encouraging regulatory landscapes, are accelerating innovation and extending the reach of gene therapeutic applications. Biological safety testing products and services are essential in gene therapy to guarantee that viral vectors and genetic materials are free of contaminants and safe for use. For example, in January 2024, the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, published a document stating that the number of gene therapies in Phase III clinical trials rose by 10% in quarter four, 2023. This represented the first such quarterly increase since quarter three, 2022. Thus, the rising demand for gene therapies is a key factor propelling the biological safety testing products and services market.

    What Are The Core Segment Classifications In The Biological Safety Testing Products And Services Market?

    The biological safety testing products and services market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Services

    2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types

    3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell

    Subsegments:

    1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents

    2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers

    3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services

    Which Trends Are Shaping The Biological Safety Testing Products And Services Market Landscape?

    Major companies within the biological safety testing products and services market are actively pursuing the development of rapid, animal-free bacterial endotoxin testing solutions to bolster patient safety and speed up drug development. This advanced methodology seeks to cut down testing durations and heighten dependability without incorporating animal-derived components. As an example, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, launched its Endosafe Trillium cartridge. This product employs recombinant technology to identify and quantify endotoxins, negating the use of animal-sourced materials. It stands as the first rapid animal-free bacterial endotoxin test offering a quicker turnaround and removing the requirement for animal-derived reagents, thus fostering greater sustainability and ethical testing procedures. The objective of this product is to provide prompt, accurate results while reducing reliance on the traditional Limulus amebocyte lysate (LAL) obtained from horseshoe crabs.

    Which Key Players Are Active In The Biological Safety Testing Products And Services Market?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Access The Complete Biological Safety Testing Products And Services Market Report:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Which Region Has The Strongest Presence In The Biological Safety Testing Products And Services Market?

    North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access Biological Safety Testing Products And Services Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company

    Food Pathogen Safety Testing Equipment And Supplies Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

    Agriculture Biologicals Testing Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/agriculture-biologicals-testing-global-market-report

    Bioanalytical Testing Services Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Rising cardiovascular disease prevalence is fueling growth in the coronary artery bypass graft market

    Rising cardiovascular disease prevalence is fueling growth in the coronary artery bypass graft market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    “How Much Will The Market Value Of The Coronary Artery Bypass Graft Market Grow Between 2026 And 2030?

    The coronary artery bypass graft market has demonstrated substantial growth over recent years. Its value is expected to rise from $13.61 billion in 2025 to $14.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. Historically, this expansion has been driven by factors such as the widespread occurrence of coronary artery disease, the scarcity of alternative revascularization methods, an increasing elderly population, the dominance of hospital-based surgical interventions, and better survival rates.

    The coronary artery bypass graft market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $21.08 billion, exhibiting a compound annual growth rate (CAGR) of 9.2%. Several factors are contributing to this projected growth, including progress in surgical methods, an increase in the number of cardiac surgeries performed, better results for patients, the proliferation of specialized cardiac facilities, and rising spending on healthcare. Key trends expected during this period involve the greater acceptance of minimally invasive CABG, a rise in off-pump procedures, increasing demand for multi-vessel bypass operations, enhanced post-operative recovery protocols, and the broadening scope of hybrid cardiac interventions.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report

    What Key Drivers Are Fueling The Growth Of The Coronary Artery Bypass Graft Market?

    The escalating incidence of cardiovascular diseases is anticipated to fuel the expansion of the coronary artery bypass graft market in the future. Cardiovascular disease (CVD) refers to a wide range of conditions affecting the heart and blood vessels. Coronary artery bypass graft (CABG) procedures are advised to diminish the risk of heart attacks by establishing alternative routes for blood circulation around obstructed or partially obstructed heart arteries. For example, a journal published by Oxford University Press, a UK-based university press of the University of Oxford, stated in March 2023 that by the year 2045, the proportion of individuals suffering from peripheral artery diseases is projected to rise by 50%. Consequently, the rising occurrence of cardiovascular diseases is propelling the growth of the coronary artery bypass graft market.

    Which Segment Categories Are Included In The Coronary Artery Bypass Graft Market Segment Analysis?

    The coronary artery bypass graft market covered in this report is segmented –

    1) By Procedure: Single Coronary Artery Bypass Graft (CABG) Surgery, Double Coronary Artery Bypass Graft (CABG) Surgery, Triple Coronary Artery Bypass Graft (CABG) Surgery, Quadruple Coronary Artery Bypass Graft (CABG) Surgery, Other Procedures

    2) By Method: Off-pump, On-pump

    3) By End-Use: Hospitals, Cardiology Clinics, Research Institutes, Other End-Users

    Subsegments:

    1) By Single Coronary Artery Bypass Graft (CABG) Surgery: Left Internal Mammary Artery (LIMA) To Left Anterior Descending Artery (LAD)

    2) By Double Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD and Another Artery

    3) By Triple Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD And Two Other Arteries

    4) By Quadruple Coronary Artery Bypass Graft (CABG) Surgery: LIMA To LAD And Three Other Arteries

    5) By Other Procedures: Off-Pump CABG, Minimally Invasive CABG, Hybrid Procedures

    What Trends Are Influencing The Coronary Artery Bypass Graft Market?

    Companies operating within the coronary artery bypass graft market are concentrating on creating innovative advancements, such as surgical robotic systems, to boost precision and lessen invasiveness, thereby enhancing patient results. These companies are also researching artificial intelligence and minimally invasive techniques to optimize procedures and decrease recovery times. A surgical robotic system is a sophisticated platform that aids surgeons in executing minimally invasive procedures with improved accuracy and visual clarity. It generally features robotic arms, advanced imaging, and a control console for the surgeon to maneuver the instruments. For instance, in October 2023, SS Innovations International Inc., a US-based company manufacturing surgical and medical instruments, unveiled its SSi Mantra surgical robotic system. This system is engineered to offer advanced and cost-effective robotic surgery solutions across various specialties, including cardiac operations. Its main advantages include superior surgical precision, reduced recovery periods via minimally invasive techniques, and the integration of machine learning for increased safety and efficiency during surgeries.

    Who Are The Active Companies Shaping The Coronary Artery Bypass Graft Market?

    Major companies operating in the coronary artery bypass graft market are CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic plc, Stryker Corporation, Northwell Health, Boston Scientific Corporation, Penn Medicine, Geisinger Health System Co, Terumo Corporation, Edwards Lifesciences Corporation, Main Line Health Inc., Getinge AB, Teleflex Incorporated, W. L. Gore & Associates Inc., Guidant Group, LivaNova PLC, AtriCure Inc., Peter Surgical, Cardiva Medical Inc., Genesee Biomedical Inc., Dextera Surgical Inc., Cardica Inc., Maquet Holding B.V. & Co.KG, Vitalitec International Medizintechnik GmbH

    Get The Full Coronary Artery Bypass Graft Market Report:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report

    Where Is The Coronary Artery Bypass Graft Market Primarily Concentrated By Region?

    North America was the largest region in the coronary artery bypass graft market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary artery bypass graft market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Coronary Artery Bypass Graft Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report

    Browse Through More Reports Similar to the Global Coronary Artery Bypass Graft Market 2026, By The Business Research Company

    Heart Transplant Market Report 2026

    https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

    Coronary Artery Disease Market Report 2026

    https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

    Aortic Stent Grafts Market Report 2026

    https://www.thebusinessresearchcompany.com/report/aortic-stent-grafts-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model”

  • Biological Safety Testing Market to Reach $11.34B by 2030

    Biological Safety Testing Market to Reach $11.34B by 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The Biological Safety Testing Products And Services Market Expected To Change From 2026 To 2030?

    The biological safety testing products and services market has experienced significant growth in recent years. It is forecast to increase from $6.12 billion in 2025 to $6.93 billion by 2026, registering a compound annual growth rate (CAGR) of 13.3%. Historically, this growth has been fueled by factors such as the rising production of vaccines and biologics, an expansion in pharmaceutical manufacturing capacity, heightened regulatory scrutiny concerning product safety, the broader adoption of cell and gene therapies, and an increase in clinical research activities.

    The biological safety testing products and services market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $11.34 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period is fueled by increasing demand for advanced biologics safety assays, rising investments in automated testing platforms, the ongoing expansion of gene and cell therapy pipelines, a growing requirement for faster release testing, and an increasing emphasis on mitigating contamination risks. Noteworthy trends for the forecast period include the increasing adoption of rapid microbial detection methods, a rising demand for automated sterility testing systems, the growing utilization of PCR-based safety testing, an expansion of outsourced biological testing services, and an enhanced focus on regulatory-compliant testing solutions.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    What Leading Drivers Are Supporting The Biological Safety Testing Products And Services Market Expansion?

    The escalating demand for gene therapies is projected to fuel the expansion of the biological safety testing products and services market moving forward. Gene therapy, a medical strategy, utilizes genes to manage or avert diseases by substituting, altering, or supplementing deficient genes. Augmented investments and research focused on gene mutation, combined with supportive regulatory environments, are further hastening innovation and expanding the scope of gene therapeutic applications. Biological safety testing products and services play a vital role in gene therapy by ensuring that viral vectors and genetic materials are free from contaminants and safe for use. An illustration of this trend is found in a document published in January 2024 by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, which reported that in quarter four, 2023, the number of gene therapies in Phase III clinical trials increased by 10%, marking the first quarterly surge of this nature since quarter three, 2022. This increasing need for gene therapies, therefore, serves as a significant impetus for the biological safety testing products and services market.

    Which Segment Categories Are Included In The Biological Safety Testing Products And Services Market Segment Analysis?

    The biological safety testing products and services market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Services

    2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types

    3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell

    Subsegments:

    1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents

    2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers

    3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services

    What Emerging Trends Are Seen In The Biological Safety Testing Products And Services Market?

    Leading companies operating in the biological safety testing products and services market are developing swift, animal-free bacterial endotoxin testing methods to enhance patient safety and accelerate drug development. This innovative approach aims to shorten testing periods and improve reliability, all without incorporating animal-based products. For example, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, unveiled the Endosafe Trillium cartridge. This product leverages recombinant technology to detect and quantify endotoxins, entirely free from animal-derived materials. It stands as the first rapid animal-free bacterial endotoxin test offering a quicker turnaround and eliminating the need for animal-derived reagents, thereby boosting sustainability and ethical testing practices. The aim of this product is to provide prompt, accurate results while decreasing reliance on the conventional Limulus amebocyte lysate (LAL) sourced from horseshoe crabs.

    Who Are The Active Companies Shaping The Biological Safety Testing Products And Services Market?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Get The Full Biological Safety Testing Products And Services Market Report:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Which Region Has The Greatest Market Share In The Biological Safety Testing Products And Services Market?

    North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Biological Safety Testing Products And Services Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company

    Bioanalytical Testing Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

    Food Pathogen Safety Testing Equipment And Supplies Market Report 2026

    https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

    Agriculture Biologicals Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/agriculture-biologicals-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biological Safety Testing Market to Reach $11.34B by 2030

    Biological Safety Testing Market to Reach $11.34B by 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Is The Market Size Of The Biological Safety Testing Products And Services Market Expected To Change From 2026 To 2030?

    The biological safety testing products and services market has experienced significant growth in recent years. It is forecast to increase from $6.12 billion in 2025 to $6.93 billion by 2026, registering a compound annual growth rate (CAGR) of 13.3%. Historically, this growth has been fueled by factors such as the rising production of vaccines and biologics, an expansion in pharmaceutical manufacturing capacity, heightened regulatory scrutiny concerning product safety, the broader adoption of cell and gene therapies, and an increase in clinical research activities.

    The biological safety testing products and services market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $11.34 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period is fueled by increasing demand for advanced biologics safety assays, rising investments in automated testing platforms, the ongoing expansion of gene and cell therapy pipelines, a growing requirement for faster release testing, and an increasing emphasis on mitigating contamination risks. Noteworthy trends for the forecast period include the increasing adoption of rapid microbial detection methods, a rising demand for automated sterility testing systems, the growing utilization of PCR-based safety testing, an expansion of outsourced biological testing services, and an enhanced focus on regulatory-compliant testing solutions.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    What Leading Drivers Are Supporting The Biological Safety Testing Products And Services Market Expansion?

    The escalating demand for gene therapies is projected to fuel the expansion of the biological safety testing products and services market moving forward. Gene therapy, a medical strategy, utilizes genes to manage or avert diseases by substituting, altering, or supplementing deficient genes. Augmented investments and research focused on gene mutation, combined with supportive regulatory environments, are further hastening innovation and expanding the scope of gene therapeutic applications. Biological safety testing products and services play a vital role in gene therapy by ensuring that viral vectors and genetic materials are free from contaminants and safe for use. An illustration of this trend is found in a document published in January 2024 by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, which reported that in quarter four, 2023, the number of gene therapies in Phase III clinical trials increased by 10%, marking the first quarterly surge of this nature since quarter three, 2022. This increasing need for gene therapies, therefore, serves as a significant impetus for the biological safety testing products and services market.

    Which Segment Categories Are Included In The Biological Safety Testing Products And Services Market Segment Analysis?

    The biological safety testing products and services market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Services

    2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types

    3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell

    Subsegments:

    1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents

    2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers

    3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services

    What Emerging Trends Are Seen In The Biological Safety Testing Products And Services Market?

    Leading companies operating in the biological safety testing products and services market are developing swift, animal-free bacterial endotoxin testing methods to enhance patient safety and accelerate drug development. This innovative approach aims to shorten testing periods and improve reliability, all without incorporating animal-based products. For example, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, unveiled the Endosafe Trillium cartridge. This product leverages recombinant technology to detect and quantify endotoxins, entirely free from animal-derived materials. It stands as the first rapid animal-free bacterial endotoxin test offering a quicker turnaround and eliminating the need for animal-derived reagents, thereby boosting sustainability and ethical testing practices. The aim of this product is to provide prompt, accurate results while decreasing reliance on the conventional Limulus amebocyte lysate (LAL) sourced from horseshoe crabs.

    Who Are The Active Companies Shaping The Biological Safety Testing Products And Services Market?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Get The Full Biological Safety Testing Products And Services Market Report:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Which Region Has The Greatest Market Share In The Biological Safety Testing Products And Services Market?

    North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Biological Safety Testing Products And Services Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company

    Bioanalytical Testing Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

    Food Pathogen Safety Testing Equipment And Supplies Market Report 2026

    https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

    Agriculture Biologicals Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/agriculture-biologicals-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • A key trend shaping the Biological Safety Testing Products And Services Market involves the Innovative Advancements In Biological Safety Testing Products And Services

    A key trend shaping the Biological Safety Testing Products And Services Market involves the Innovative Advancements In Biological Safety Testing Products And Services

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Is The Estimated Market Size Of The Biological Safety Testing Products And Services Market During 2026–2030?

    The market for biological safety testing products and services has experienced substantial growth in recent times. This market is projected to expand from $6.12 billion in 2025 to $6.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.3%. Historically, this expansion has been driven by several factors, including an increase in the production of vaccines and biologics, an enlargement of pharmaceutical manufacturing capabilities, heightened regulatory examination of product safety, the broader acceptance and use of cell and gene therapies, and an uptick in clinical research endeavors.

    The biological safety testing products and services market is projected to experience swift expansion over the coming years. This market is forecast to reach a size of $11.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. Several factors are driving this anticipated growth, including a surge in demand for sophisticated biologics safety assays, increased capital allocation towards automated testing platforms, the broadening scope of gene and cell therapy pipelines, an escalating requirement for more rapid release testing, and a heightened focus on reducing contamination risks. Key trends anticipated during this period encompass the wider integration of rapid microbial detection techniques, an increasing call for automated sterility testing systems, a growing reliance on PCR-based safety testing, the proliferation of outsourced biological testing provisions, and a stronger commitment to testing solutions that adhere to regulatory standards.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

    What Underlying Factors Are Accelerating The Growth Of The Biological Safety Testing Products And Services Market?

    The increasing demand for gene therapies is anticipated to stimulate the growth of the biological safety testing products and services market in the future. Gene therapy is a medical approach that employs genes to treat or prevent diseases by substituting, modifying, or supplementing flawed genes. Enhanced investment and research efforts concerning gene mutation, coupled with supportive regulatory environments, further propel innovation and expand the scope of gene therapeutic applications. Biological safety testing products and services within gene therapy are essential for ensuring that viral vectors and genetic materials remain free of contaminants and are safe for use. For example, in January 2024, a document published by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, indicated that in quarter four, 2023, the count of gene therapies in Phase III clinical trials expanded by 10%, which was the first quarterly increase of this nature since quarter three, 2022. Thus, the escalating demand for gene therapies is a significant driver for the biological safety testing products and services market.

    How Are The Various Segments Of The Biological Safety Testing Products And Services Market Categorized?

    The biological safety testing products and services market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Services

    2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types

    3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell

    Subsegments:

    1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents

    2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers

    3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services

    What Key Developments And Trends Are Impacting The Biological Safety Testing Products And Services Market?

    Leading companies operating within the biological safety testing products and services market are actively pursuing the creation of rapid, animal-free bacterial endotoxin testing solutions to elevate patient safety and expedite the drug development process. This inventive method seeks to minimize testing time and improve reliability without incorporating animal-based products. As an illustration, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, introduced its Endosafe Trillium cartridge, which employs recombinant technology to identify and measure endotoxins without utilizing animal-derived materials. This marks the first rapid animal-free bacterial endotoxin test, offering a quicker turnaround time and eliminating the need for animal-derived reagents, thereby boosting sustainability and ethical testing practices. The aim of this product is to deliver swift, accurate results while lessening dependence on the conventional Limulus amebocyte lysate (LAL) obtained from horseshoe crabs.

    Which Major Firms Influence Developments In The Biological Safety Testing Products And Services Market?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Read the full biological safety testing products and services market report here:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Which Region Is Projected To Dominate The Biological Safety Testing Products And Services Market During The Forecast Period?

    North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Biological Safety Testing Products And Services Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company

    Food Pathogen Safety Testing Equipment And Supplies Global Market Report

    https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

    Agriculture Biologicals Testing Global Market Report

    https://www.thebusinessresearchcompany.com/report/agriculture-biologicals-testing-global-market-report

    Bioanalytical Testing Services Global Market Report

    https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biological Safety Testing Products And Services Market Trends and Insights: Global Forecast to 2030

    Biological Safety Testing Products And Services Market Trends and Insights: Global Forecast to 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the biological safety testing products and services market from 2026–2035 with trusted insights from The Business Research Company

    What growth pattern is forecast for the Biological Safety Testing Products And Services Market size between 2026 and 2035?

    The biological safety testing products and services market has witnessed substantial growth in recent years. This market is set to increase from $6.12 billion in 2025 to $6.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. The expansion observed in the past can be ascribed to several factors, including the escalating production of vaccines and biologics, the enlargement of pharmaceutical manufacturing capabilities, more stringent regulatory examination of product safety, the wider embrace of cell and gene therapies, and the rise in clinical research operations.

    The biological safety testing products and services market size is anticipated to experience substantial growth in the upcoming years, projected to reach $11.34 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period can be attributed to several factors including increasing demand for advanced biologics safety assays, rising investments in automated testing platforms, the expansion of gene and cell therapy pipelines, a growing need for faster release testing, and an increasing emphasis on contamination risk mitigation. Major trends expected in the forecast period encompass the increasing adoption of rapid microbial detection methods, rising demand for automated sterility testing systems, the growing use of PCR-based safety testing, the expansion of outsourced biological testing services, and an enhanced focus on regulatory-compliant testing solutions.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

    Which Drivers Are Impacting Market Performance In The Biological Safety Testing Products And Services Market?

    The increasing requirement for gene therapies is anticipated to drive the expansion of the biological safety testing products and services market in the future. Gene therapy represents a medical strategy that employs genes to address or avert illnesses through the replacement, alteration, or addition of defective genetic material. Greater investment and scientific inquiry into gene mutation, combined with favorable regulatory frameworks, further stimulate advancements and broaden the uses of gene therapies. Within gene therapy, biological safety testing products and services are crucial for guaranteeing that viral vectors and genetic components are free from contaminants and safe for application. As an illustration, a document released by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, indicated in January 2024 that the quantity of gene therapies undergoing Phase III clinical trials expanded by 10% in quarter four, 2023. This marked the initial quarterly rise of its kind since quarter three, 2022. Consequently, the rising demand for gene therapies acts as a primary catalyst for the market of biological safety testing products and services.

    Which Segments Are Contributing To The Growth Of The Biological Safety Testing Products And Services Market?

    The biological safety testing products and services market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Services

    2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types

    3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell

    Subsegments:

    1) By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents

    2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers

    3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services

    Which Trends Are Shaping Activity Within The Biological Safety Testing Products And Services Market?

    Leading enterprises within the biological safety testing products and services market are actively engaged in creating swift, animal-free methods for bacterial endotoxin detection, with the dual objective of improving patient safety and accelerating drug development processes. This novel strategy is designed to decrease the duration of testing and boost accuracy, all without incorporating animal-derived components. An illustrative example occurred in January 2024, when Charles River Laboratories International, a pharmaceutical and biotechnology firm based in the U.S., launched its Endosafe Trillium cartridge. This product utilizes recombinant technology to identify and measure endotoxins without relying on materials sourced from animals. It stands as the initial rapid animal-free bacterial endotoxin test, offering quicker processing times and eliminating the necessity for animal-based reagents, thereby contributing to environmental responsibility and ethical testing standards. The primary goal of this particular product is to deliver quick, precise outcomes, simultaneously diminishing dependence on the conventional Limulus amebocyte lysate (LAL) traditionally obtained from horseshoe crabs.

    Who Are The Prominent Global Companies Shaping The Biological Safety Testing Products And Services Market Landscape?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Which Geographic Areas Are Emerging As Strong Markets For The Biological Safety Testing Products And Services Market?

    North America was the largest region in the biological safety testing products and services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Biological Safety Testing Products And Services Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2026, By The Business Research Company

    Bioanalytical Testing Services Market Report 2026

    https://www.thebusinessresearchcompany.com/report/bioanalytical-testing-services-global-market-report

    Food Pathogen Safety Testing Equipment And Supplies Market Report 2026

    https://www.thebusinessresearchcompany.com/report/food-pathogen-safety-testing-equipment-and-supplies-global-market-report

    Agriculture Biologicals Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/agriculture-biologicals-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Emerging Trends Are Driving The Biological Safety Testing Products And Services Market Toward $10.04 Billion By 2029?

    Which Emerging Trends Are Driving The Biological Safety Testing Products And Services Market Toward $10.04 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Are The Market Size Estimates For The Biological Safety Testing Products And Services Market?

    There has been significant growth in the size of the market for biological safety testing products and services in recent years, expanding from $5.4 billion in 2024 to an anticipated $6.12 billion in 2025. This translates to a compound annual growth rate (CAGR) of 13.3%. Several factors have contributed to the growth seen in the historical period, including the high incidence of target diseases, increased production of next-generation biologics, a higher demand for biologics, more frequent use of testing tools, expansion in the pharmaceutical and biotechnology sectors, and the growing importance of regulatory compliance.

    The market for biological safety testing products and services is projected to experience a swift expansion in the coming years, with its value anticipated to reach $10.04 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.2%. Reasons for this growth during the forecasted period include the heightened emphasis on assessing the safety and efficacy of these products for tackling health issues, progressing creation of novel therapeutics and treatments, increasing interest in cell and gene therapy development, growing investment within the biopharmaceutical sector, and increased government initiatives that encourage biopharmaceutical safety. The forecast period is likely to see trends such as technological progression, heightened need for bioburden testing, increased biopharmaceutical and biologics investments, regulatory adherence pushing the market’s adoption, and key player mergers and acquisitions.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

    Which Growth Drivers Are Shaping The Biological Safety Testing Products And Services Market Outlook?

    The escalating need for gene therapies is forecasted to boost the biological safety testing products and services market’s progress. Gene therapy, a healthcare strategy involving the use of genes to prevent or cure disease by replacing, modifying, or supplementing defective genes, is seeing increased investment and research. This, paired with a favourable regulatory atmosphere, is driving innovation and broadening the scope of gene therapeutics. Biological safety testing products and services play a crucial role in ensuring viral vectors and genetic materials used in gene therapy are free from contaminants and safe to utilize. For instance, a document released in January 2024 by the American Society of Gene & Cell Therapy, a nonprofit medical and scientific outfit based in the US, revealed that in quarter four of 2023, the number of gene therapies in Phase III clinical trials saw a growth of 10%. This was the initial quarterly surge of this kind since quarter three in 2022. Consequently, the growing need for gene therapies is fuelling the biological safety testing products and services market.

    What Are The Primary Segmentation Parameters In The Biological Safety Testing Products And Services Market?

    The biological safety testing products and servicesmarket covered in this report is segmented –

    1) By Product: Reagents And Kits; Instruments; Services

    2) By Test Type: Endotoxin Tests; Sterility Tests; Cell Line Authentication And Characterization Tests; Bioburden Tests; Adventitious Agent Detection Tests; Residual Host Contamination Detection Tests; Other Test Types

    3) By Application: Vaccines And Therapeutics; Blood And Blood-Based Products; Gene Therapy; Tissue And Tissue-based Products; Stem Cell

    Subsegments:

    1)By Reagents And Kits: Endotoxin Testing Kits; Mycoplasma Detection Kits; Sterility Testing Kits; Microbial Detection Reagents; Cell Culture Media Reagents

    2) By Instruments: PCR Instruments; Microplate Readers; Bioluminescence Detection Systems; Automated Cell Culture Systems; ELISA Readers

    3) By Services: Microbial Testing Services; Biocompatibility Testing Services; Endotoxin Testing Services; Environmental Monitoring Services; Consulting And Validation Services

    How Are Industry Trends Steering The Expansion Of The Biological Safety Testing Products And Services Market?

    Key players in the biological safety testing products and services sector are advancing by creating animal-free bacterial endotoxin testing methods which augment patient safety and hasten drug development process. This pioneering strategy aims to cut down testing duration and boost reliability without involving animal-based substances. For example, Charles River Laboratories International, a pharmaceutical and biotechnological firm based in the US, launched the Endosafe Trillium cartridge in January 2024. This cartridge uses recombinant technology to locate and measure endotoxins without utilizing animal-sourced materials. It is the maiden rapid animal-free bacterial endotoxin test that includes a quicker response time and eradicates the requirement for animal-sourced reagents, thereby enhancing sustainability and ethical testing standards. This merchandise aims to deliver swift, precise results while diminishing reliance on the conventional Limulus amebocyte lysate (LAL) sourced from horseshoe crabs.

    Which Organizations Are At The Forefront Of The Biological Safety Testing Products And Services Market?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    Which Region Holds The Greatest Opportunity For Biological Safety Testing Products And Services Market Expansion?

    North America was the largest region in the biological safety testing products and services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2025, By The Business Research Company

    Biological Wastewater Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/biological-wastewater-treatment-global-market-report

    Cbrn Chemical Biological Radiological And Nuclear Security Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cbrn-chemical-biological-radiological-and-nuclear-security-global-market-report

    Biological Seed Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/biological-seed-treatment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biological Safety Testing Products And Services Market Forecast: What to Expect by 2029

    Biological Safety Testing Products And Services Market Forecast: What to Expect by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Are The Forecasted Market Size Estimates For The Biological Safety Testing Products And Services Market Between 2025 And 2029?

    The market for biological safety testing products and services has experienced significant expansion recently. This market is projected to expand from $5.4 billion in 2024 to $6.12 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 13.3%. Historically, this expansion has been driven by factors such as the increased occurrence of relevant diseases, the growing manufacturing of next-generation biologics, an escalating demand for biologics, a greater embrace of testing instruments, the development of the pharmaceutical and biotechnology sectors, and a heightened focus on adherence to regulations.

    The biological safety testing products and services market is projected to experience rapid growth over the next few years. It is anticipated to expand to “$10.04 billion” by “2029”, exhibiting a compound annual growth rate (CAGR) of “13.2%”. This growth during the forecast period can be attributed to the increasing importance of assessing their safety and effectiveness in treating health problems, the expanding development of new therapeutics and treatments, a rising interest in developing cell and gene therapies, escalating investments in the biopharmaceutical sector, and growing government initiatives to promote biopharmaceutical safety. Major trends expected in this period include technological advancements, an increasing demand for bioburden testing, heightened investments in biopharmaceuticals and biologics, regulatory compliance driving market adoption, and mergers and acquisitions among key industry players.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

    Which Drivers Are Supporting Growth Of The Biological Safety Testing Products And Services Market?

    The increasing need for gene therapies is anticipated to drive the expansion of the biological safety testing products and services market in the future. Gene therapy represents a medical strategy employing genes to address or avert illnesses through the replacement, alteration, or addition of defective genes. Enhanced investment and research focusing on gene mutation, combined with favorable regulatory frameworks, are accelerating innovation and broadening the applications of gene therapeutics. In the context of gene therapy, biological safety testing products and services are crucial for guaranteeing that viral vectors and genetic materials are free from contaminants and safe for application. For example, a document released by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, in January 2024, indicated that in quarter four, 2023, there was a 10% rise in the number of gene therapies in Phase III clinical trials. This marked the first such quarterly increase observed since quarter three, 2022. Consequently, the escalating demand for gene therapies is a key driver for the biological safety testing products and services market.

    How Is The Biological Safety Testing Products And Services Market Classified Into Different Segments?

    The biological safety testing products and servicesmarket covered in this report is segmented –

    1) By Product: Reagents And Kits; Instruments; Services

    2) By Test Type: Endotoxin Tests; Sterility Tests; Cell Line Authentication And Characterization Tests; Bioburden Tests; Adventitious Agent Detection Tests; Residual Host Contamination Detection Tests; Other Test Types

    3) By Application: Vaccines And Therapeutics; Blood And Blood-Based Products; Gene Therapy; Tissue And Tissue-based Products; Stem Cell

    Subsegments:

    1)By Reagents And Kits: Endotoxin Testing Kits; Mycoplasma Detection Kits; Sterility Testing Kits; Microbial Detection Reagents; Cell Culture Media Reagents

    2) By Instruments: PCR Instruments; Microplate Readers; Bioluminescence Detection Systems; Automated Cell Culture Systems; ELISA Readers

    3) By Services: Microbial Testing Services; Biocompatibility Testing Services; Endotoxin Testing Services; Environmental Monitoring Services; Consulting And Validation Services

    Which Key Trends Are Expected To Influence The Biological Safety Testing Products And Services Market In The Coming Years?

    Leading companies in the biological safety testing products and services market are creating swift, animal-free bacterial endotoxin tests with the goal of improving patient safety and speeding up drug development. This innovative methodology aims to decrease testing periods and enhance reliability without incorporating animal-based products. For example, in January 2024, Charles River Laboratories International, a US-based pharmaceutical and biotechnology company, launched the Endosafe Trillium cartridge. This device uses recombinant technology to identify and quantify endotoxins, completely avoiding animal-derived materials. It stands as the first rapid animal-free bacterial endotoxin test offering a quicker turnaround time and removing the requirement for animal-derived reagents, thereby promoting greater sustainability and ethical testing approaches. The objective of this product is to deliver fast, accurate results while lessening dependence on the traditional Limulus amebocyte lysate (LAL) extracted from horseshoe crabs.

    Who Are The Core Companies Influencing The Biological Safety Testing Products And Services Market Landscape?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    How Does The Biological Safety Testing Products And Services Market Perform Across Key Geographic Regions?

    North America was the largest region in the biological safety testing products and services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Biological Safety Testing Products And Services Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp

    Browse Through More Reports Similar to the Global Biological Safety Testing Products And Services Market 2025, By The Business Research Company

    Biological Wastewater Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/biological-wastewater-treatment-global-market-report

    Cbrn Chemical Biological Radiological And Nuclear Security Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cbrn-chemical-biological-radiological-and-nuclear-security-global-market-report

    Biological Seed Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/biological-seed-treatment-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Biological Safety Testing Products And Services Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

    Biological Safety Testing Products And Services Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    #What is the Projected CAGR for the Biological Safety Testing Products And Services Market Size from 2025 to 2034?#_x000D_

    The market size for products and services in biological safety testing has seen significant expansion in the past few years. There is expected growth from $5.4 billion in 2024 to $6.12 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.3%. Factors contributing to this growth during the historic period include an increase in target diseases, the surging production of next-generation biologics, a rise in demand for biologics. It also encompasses the growing adoption of testing tools, expansion in the pharmaceutical and biotechnology sectors, and an intensifying focus on regulatory compliance._x000D_

    _x000D_

    The market size of products and services for biological safety testing is anticipated to witness a significant surge in the coming years. It’s estimated to expand to $10.04 billion by 2029, with a compound annual growth rate (CAGR) of 13.2%. The growth during the forecast period can be attributed to the heightened need for evaluating the safety and efficiency of these products in treating health issues, in addition to the continued new therapeutics and treatments’ development, increased interest in cell and gene therapies, and increased investments in the biopharmaceutical sector. Furthermore, government efforts to enhance biopharmaceutical safety have also influenced this growth. The predictive period will also see trends like technological advancements, greater demand for bioburden testing, rising investments in biopharmaceuticals and biologics, regulatory compliance steering uptake, and mergers and acquisitions amongst leading players._x000D_

    _x000D_

    #Download a free sample to assess the report’s scope and structure:#_x000D_

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp_x000D_

    _x000D_

    #What External and Internal Drivers Are Contributing to the Growth of theBiological Safety Testing Products And Services Market?#_x000D_

    The biological safety testing products and services market is anticipated to flourish due to the rising demand for gene therapies. Gene therapy, a medical approach that treats or prevents diseases by manipulating genes, is gaining momentum. Factors such as escalated investment and research in gene mutation, and favorable regulatory environments, are propelling advancements in gene therapeutic applications. Gene therapy utilizes biological safety testing products and services to ensure the absence of contaminants in viral vectors and genetic materials. As per documentation published in January 2024 by the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials witnessed a growth of 10% in the fourth quarter of 2023, a remarkable first quarterly growth since the third quarter of 2022. Hence, the burgeoning demand for gene therapies is driving the biological safety testing products and services market._x000D_

    _x000D_

    #What Segment Types Define the Biological Safety Testing Products And Services Market Structure?#_x000D_

    The biological safety testing products and servicesmarket covered in this report is segmented – _x000D_

    _x000D_

    1) By Product: Reagents And Kits; Instruments; Services_x000D_

    2) By Test Type: Endotoxin Tests; Sterility Tests; Cell Line Authentication And Characterization Tests; Bioburden Tests; Adventitious Agent Detection Tests; Residual Host Contamination Detection Tests; Other Test Types_x000D_

    3) By Application: Vaccines And Therapeutics; Blood And Blood-Based Products; Gene Therapy; Tissue And Tissue-based Products; Stem Cell_x000D_

    _x000D_

    Subsegments:_x000D_

    1)By Reagents And Kits: Endotoxin Testing Kits; Mycoplasma Detection Kits; Sterility Testing Kits; Microbial Detection Reagents; Cell Culture Media Reagents _x000D_

    2) By Instruments: PCR Instruments; Microplate Readers; Bioluminescence Detection Systems; Automated Cell Culture Systems; ELISA Readers _x000D_

    3) By Services: Microbial Testing Services; Biocompatibility Testing Services; Endotoxin Testing Services; Environmental Monitoring Services; Consulting And Validation Services_x000D_

    _x000D_

    _x000D_

    #Request customized data on this market:#_x000D_

    https://www.thebusinessresearchcompany.com/customise?id=18258&type=smp_x000D_

    _x000D_

    #Which Geographic Areas Hold the Strongest Growth Potential in the Biological Safety Testing Products And Services Market?#_x000D_

    North America was the largest region in the biological safety testing products and services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

    _x000D_

    #What Long-Term Trends Are Transforming the Competitive Landscape of the Biological Safety Testing Products And Services Market?#_x000D_

    Leading firms in the market for biological safety testing products and services are creating fast, animal-free bacterial endotoxin tests to improve patient safety and speed up drug development. This novel method aims to cut down on testing time and increase reliability, without requiring any animal-derived products. For example, Charles River Laboratories International, a pharmaceutical and biotechnology company based in the US, launched the Endosafe Trillium cartridge in January 2024. This makes use of recombinant technology to identify and measure endotoxins, without the use of any materials derived from animals. It’s the inaugural quick, animal-free bacterial endotoxin test that delivers quicker results and gets rid of the requirement for animal-derived reagents, thereby promoting sustainable and ethical testing methods. The goal of this product is to offer fast, precise results while reducing dependence on the conventional Limulus amebocyte lysate (LAL) which is obtained from horseshoe crabs._x000D_

    _x000D_

    #View the full report here:#_x000D_

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report_x000D_

    _x000D_

    #What Is the Definition of the Biological Safety Testing Products And Services Market?#_x000D_

    Biological safety testing products and services refer to equipment and methods used to confirm that biological products are safe and uncontaminated by harmful agents, ensuring their safety and effectiveness for medical use. Its primary aim is to detect and prevent contamination by bacteria, viruses, fungi, and other pathogens._x000D_

    _x000D_

    #Purchase the full report and get a swift delivery:#_x000D_

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18258_x000D_

    _x000D_

    #About The Business Research Company:#_x000D_

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

    _x000D_

    #Get in touch with us:#_x000D_

    The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

    Americas +1 310-496-7795_x000D_

    Europe +44 7882 955267_x000D_

    Asia & Others +44 7882 955267 & +91 8897263534_x000D_

    Email us at info@tbrc.info_x000D_

    _x000D_

    #Follow us on:#_x000D_

    _x000D_

    LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Growth Opportunities and Trends in the Biological Safety Testing Products And Services Market: Key Insights for 2025-2034

    Growth Opportunities and Trends in the Biological Safety Testing Products And Services Market: Key Insights for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the biological safety testing products and services market grown over the years?

    The biological safety testing products and services market has seen rapid growth in recent years. It will grow from $5.4 billion in 2024 to $6.14 billion in 2025, at a CAGR of 13.7%. This growth is driven by the prevalence of target diseases, increased production of next-generation biologics, rising demand for biologics, higher adoption of testing tools, the expanding pharmaceutical and biotechnology industries, and a greater focus on regulatory compliance.

    What Is the forecasted market size and growth rate for the biological safety testing products and services market?

    The biological safety testing products and services market is expected to grow to $10.11 billion by 2029, at a CAGR of 13.3%. Growth drivers include the need for safety and effectiveness evaluations, increasing biopharmaceutical development, interest in cell and gene therapies, rising biopharmaceutical investments, and government initiatives for biopharmaceutical safety. Key trends include technological advancements, bioburden testing demand, rising investments in biologics, regulatory compliance, and industry consolidation.

    Get your biological safety testing products and services market report here!

    https://www.thebusinessresearchcompany.com/report/biological-safety-testing-products-and-services-global-market-report

    What are the major factors driving growth in the biological safety testing products and services market?

    The increasing demand for gene therapies is anticipated to drive the growth of the biological safety testing products and services market. Gene therapy, which uses genes to treat or prevent diseases by altering or replacing faulty genes, is gaining momentum due to greater investment, research in gene mutations, and favorable regulatory environments. Biological safety testing ensures that viral vectors and genetic materials are free from contaminants. For example, in January 2024, the American Society of Gene & Cell Therapy reported a 10% growth in the number of gene therapies in Phase III clinical trials during Q4 2023, marking the first such increase since Q3 2022. As a result, the demand for gene therapies is propelling the biological safety testing market.

    What key areas define the segmentation of the global biological safety testing products and services Market?

    The biological safety testing products and services market covered in this report is segmented –

    1) By Product: Reagents And Kits, Instruments, Services

    2) By Test Type: Endotoxin Tests, Sterility Tests, Cell Line Authentication And Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Other Test Types

    3) By Application: Vaccines And Therapeutics, Blood And Blood-Based Products, Gene Therapy, Tissue And Tissue-based Products, Stem Cell

    Subsegments:

    1)By Reagents And Kits: Endotoxin Testing Kits, Mycoplasma Detection Kits, Sterility Testing Kits, Microbial Detection Reagents, Cell Culture Media Reagents

    2) By Instruments: PCR Instruments, Microplate Readers, Bioluminescence Detection Systems, Automated Cell Culture Systems, ELISA Readers

    3) By Services: Microbial Testing Services, Biocompatibility Testing Services, Endotoxin Testing Services, Environmental Monitoring Services, Consulting And Validation Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=18258&type=smp

    What are the top market players propelling the growth of the biological safety testing products and services industry?

    Major companies operating in the biological safety testing products and services market are Merck KGaA, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, SGS Société Générale de Surveillance SA, Eurofins Scientific, Agilent Technologies Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Charles River Laboratories Inc., BioMérieux SA, Almac Group, Samsung Biologics Co. Ltd., Maravai LifeSciences Holdings Inc., Genscript Biotech Corp, Wako Pure Chemical Industries Ltd., Associates of Cape Cod Inc., InvivoGen S.A.S., Microcoat Biotechnologie GmbH, BSL BIOSERVICE Scientific Laboratories Munich GmbH, Redberry, PathoQuest

    What are the key trends shaping the future of the biological safety testing products and services market?

    Companies in the biological safety testing products and services market are working on animal-free bacterial endotoxin testing to ensure patient safety and accelerate drug development. This approach eliminates the use of animal-based products, improving testing reliability and speed. For instance, in January 2024, Charles River Laboratories introduced the Endosafe Trillium cartridge, a rapid animal-free bacterial endotoxin test using recombinant technology. This method provides quicker results and eliminates animal-derived materials, promoting sustainable and ethical testing practices.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18258

    What regions are dominating the biological safety testing products and services market growth?

    North America was the largest region in the biological safety testing products and services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biological safety testing products and services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Non-invasive Prenatal Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

    Food and Beverage Testing Kits Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/food-and-beverage-testing-kits-global-market-report

    Microbiological Testing Of Water Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/microbiological-testing-of-water-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: